Signet Financial Management, LLC Amgen Inc Transaction History

Signet Financial Management, LLC

$765 Million
Q4 2024

A detailed history of Signet Financial Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Signet Financial Management, LLC holds 7,267 shares of AMGN stock, worth $2.14 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

7,267

Previous 7,614 4.56%

Holding current value

$2.14 Million

Previous $2.45 Million 22.79%

% of portfolio

0.25%

Previous 0.32%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$258.78 - $328.31 $89,796 - $113,923	-347 Reduced 4.56%	7,267 $1.89 Million
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $114,161 - $124,493	-369 Reduced 4.62%	7,614 $2.45 Million
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $44,930 - $54,602	-171 Reduced 2.1%	7,983 $2.49 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $199,232 - $240,498	741 Added 10.0%	8,154 $2.32 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $44,747 - $50,480	-175 Reduced 2.31%	7,413 $2.14 Million
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $118,508 - $147,131	-542 Reduced 6.67%	7,588 $2.04 Million
Q2 2023 Jul 18, 2023	SELL	$214.27 - $253.37 $61,281 - $72,463	-286 Reduced 3.4%	8,130 $1.81 Million
Q1 2023 Apr 17, 2023	BUY	$225.79 - $275.2 $95,509 - $116,409	423 Added 5.29%	8,416 $2.03 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $14,199 - $18,042	62 Added 0.78%	7,993 $2.1 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $68,011 - $76,704	303 Added 3.97%	7,931 $1.79 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $222,865 - $248,010	966 Added 14.5%	7,628 $1.86 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $6,358 - $7,034	-29 Reduced 0.43%	6,662 $1.61 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $133,647 - $152,947	-672 Reduced 9.13%	6,691 $1.51 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $1.56 Million - $1.83 Million	7,363 New	7,363 $1.57 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $1.66 Million - $1.84 Million	-7,112 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $81,662 - $95,164	368 Added 5.46%	7,112 $1.77 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $53,662 - $63,902	248 Added 3.82%	6,744 $1.55 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $323,113 - $359,328	-1,377 Reduced 17.49%	6,496 $1.5 Million
Q2 2020 Aug 18, 2020	BUY	$197.81 - $242.74 $90,201 - $110,689	456 Added 6.15%	7,873 $1.88 Million
Q1 2020 May 20, 2020	SELL	$182.24 - $241.7 $88,204 - $116,982	-484 Reduced 6.13%	7,417 $1.76 Million
Q4 2019 Jan 23, 2020	BUY	$189.21 - $243.2 $40,869 - $52,531	216 Added 2.81%	7,901 $1.91 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $19,674 - $23,574	113 Added 1.49%	7,685 $1.7 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $4,834 - $5,666	29 Added 0.38%	7,572 $1.33 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $176,709 - $199,190	-977 Reduced 11.47%	7,543 $1.33 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $74,928 - $87,465	420 Added 5.19%	8,520 $1.66 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $17,973 - $20,262	97 Added 1.21%	8,100 $1.68 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $183,153 - $205,720	-1,103 Reduced 12.11%	8,003 $1.48 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $847 - $990	-5 Reduced 0.05%	9,106 $1.55 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $107,519 - $120,131	-637 Reduced 6.53%	9,111 $1.58 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.63 Million - $1.86 Million	9,748	9,748 $1.82 Million

Others Institutions Holding AMGN

# of Institutions

3,098

Shares Held

404M

Call Options Held

7.75M

Put Options Held

6.9M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signet Financial Management, LLC with notifications on news.

Account

Signet Financial Management, LLC Amgen Inc Transaction History